Pharma and Health Care

Thanks to our profound knowledge of the Swiss health care system and the practice of the authorities and the courts, we advise our clients in a targeted and efficient manner. We mainly serve pharmaceutical, biotech and medical device companies, but also other players in the healthcare sector. Our focus is on marketing authorization and market access, reimbursement by health insurance, advertising, manufacturing and distribution, collaboration with doctors and hospitals, clinical trials, licensing of intellectual property rights, competition and antitrust law, eHealth, data protection as well as product liability.

Our expertise covers specifically:

  • Drafting and negotiating distribution, cooperation, licensing, clinical trial, advisory, service, sponsorship and support agreements
  • Advice and representation in dealings with Swissmedic and the FOPH (Swiss Federal Office of Public Health) in all therapeutic products legislation matters
  • Appeal proceedings
  • Review of advertising and cooperation with professionals for compliance with Swiss legislation, the Swiss Pharma Code and the Pharma Cooperation Code (Compliance)
  • Representation in administrative and administrative criminal proceedings
  • Review of Standard Operating Procedures
  • Due diligence reviews and transactions
  • Advice on human research law
  • Drafting and negotiating clinical trial agreements
  • Representation in unfair competition proceedings
  • Representation in product liability proceedings
  • Advice on data protection, information technology, new media and eHealth projects
Scherrer Frank

Frank
Scherrer

Partner

Speck Beat

Beat
Speck

Partner

Näf Patrick

Patrick
Näf

Senior Associate

Boller Marcel

Marcel
Boller

Associate

Holderegger Ines

Ines
Holderegger

Associate

Roos Dominique

Dominique
Roos

Associate

Publications

Chambers and PartnersThe Legal 500Leaders League

The exchange of opinion was always useful as we often got interesting ideas from their side, seeing as they often deal with difficult cross-border situations.

Chambers and Partners